Uptake Characteristics of Oligonucleotides in the Isolated Rat Liver Perfusion System
Authors:
- Ram I. MahatoRMRam I. Mahato
- Mitsunobu YoshidaMYMitsunobu Yoshida
- Taro KanamaruTKTaro Kanamaru
- Mitsuru HashidaMHMitsuru Hashida
- 1 January 1996
- journal article
- research article
- Published by SAGE Publications in Antisense and Nucleic Acid Drug Development
- Vol. 6 (3) , 177-183
Abstract
The objective of this study was to examine the hepatic disposition characteristics of 20-mer model phosphodiester oligonucleotide (PO) and its partially phosphorothioated (PS3) and fully phosphorothioated (PS) derivatives in the single-pass isolated rat liver perfusion system. [32P]-labeled oligonucleotides were momentarily introduced into this system through the portal vein as a bolus input mode, and the venous outflow patterns were evaluated using statistical moment analysis. The apparent volumes of distribution of these oligonucleotides were greater than those of reference substances for vascular space (erythrocytes) and extracellular space (human serum albumin), indicating a significant interaction between oligonucleotides and the liver. Significant hepatic uptake of oligonucleotides was also observed. About 20%, 36%, and 52% of the injected dose (3 μg/rat) was taken up by the liver during a single passage after bolus injection of PO, PS3, and PS, respectively. In the case of PS injection, slow efflux from the liver was observed in the latter phase of perfusion. This suggests that the hepatic uptake process of these oligonucleotides greatly depended on their types. The results of collagenase perfusion experiments suggest that PS3 oligonucleotides were taken up by both liver parenchymal and non-parenchymal cells. The amount of total recovery in the liver decreased substantially by coadministration of polyinosinic acid, dextran sulfate, polycytidic acid and 4-acetamido-4‵-isothiocyano-stilbene-2,2‵-disulfonic acid. This suggests that PS3 was taken up by the liver as an anionic molecule in a nonspecific manner.Keywords
This publication has 30 references indexed in Scilit:
- In vivo stability, disposition and metabolism of a “hybrid” oligonucleotide phosphorothioate in ratsBiochemical Pharmacology, 1995
- Phosphorothioate oligonucleotides bind in a non sequence‐specific manner to the nucleolar protein C23/nucleolinFEBS Letters, 1995
- Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1Biochemical Pharmacology, 1995
- Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular MatrixJournal of Biological Chemistry, 1995
- Pharmacokinetic disposition analysis of lipophilic drugs injected with various lipid carriers in the single-pass rat liver perfusion systemInternational Journal of Pharmaceutics, 1995
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Oligodeoxynucleotides as Antisense Inhibitors of Gene Expression1992
- A new method for assessment of drug disposition in muscle: Application of statistical moment theory to local perfusion systemsJournal of Pharmacokinetics and Biopharmaceutics, 1985
- The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophagesJournal of Supramolecular Structure, 1980
- Statistical moments in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978